Shardul Amarchand Mangaldas & Co. has advised Krishna Institute of Medical Sciences Limited (KIMS), one of the key healthcare corporate groups in India, on its Qualified Institutions Placement (QIP) aggregating to INR 1,500 crore. Cyril Amarchand Mangaldas guided the book running lead managers on this QIP.
IIFL Capital Services and Jefferies India were the BRLMs on this QIP.
The QIP comprised participation from a diverse set of institutional investors, including the International Finance Corporation (IFC), as well as leading mutual funds and insurance companies such as HSBC Mutual Fund, Edelweiss Mutual Fund, Axis Mutual Fund, ICICI Prudential Life Insurance, HDFC Life Insurance and Kotak Mahindra Life Insurance.
The proceeds of the QIP are proposed to be utilised towards repayment and/or prepayment of certain outstanding borrowings availed by the Company and certain of its subsidiaries.
SAM’s transaction team consisted of partner and national practice head – capital markets Prashant Gupta, partner Ruth Chenchiah, principal associate Ritika Khare, senior associate Anoushka PV, associate Anaya Jain, and associate Kunika Agarwal.
CAM’s team was led by senior partner Yash Ashar, and partner (regional co-head – capital markets – south) Reuben Chacko, with the support from partner Abhyuday Bhotika, principal associates Aniran Ghosal and Sravya Surapaneni, senior associate designate Bhaskar Kumar, and associates Namita Kaushik, Eashan Agrawal and Mitali Mangalam.
